Henry Ellenbogen’s Evolent Health EVH Stock Holding History

Henry Ellenbogen’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,423,293	Closed	-$72.3M	–	50
2025 Q2	$72.3M	Buy	+6,423,293	New	+$59M	0.55%	38

Other funds holding EVH

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Henry Ellenbogen's EVH Position: Q3 2025 in Review

Henry Ellenbogen sold out of Evolent Health (EVH) in Q3 2025, closing a stake of 6,423,293 shares — an estimated $72.3M sold.

Henry Ellenbogen first reported a position in EVH in Q2 2025 and held it in 1 quarter. The position peaked at $72.3M in Q2 2025. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

Henry Ellenbogen reported no remaining Evolent Health position as of Q3 2025 after selling out during the quarter.
Henry Ellenbogen sold 6,423,293 Evolent Health shares in Q3 2025, an estimated $72.3M.
Henry Ellenbogen first reported a position in Evolent Health in Q2 2025 and held it in 1 quarter.
Henry Ellenbogen's Evolent Health position peaked at $72.3M in Q2 2025.
240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Durable Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.